Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Basic Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Myrovlytis Technology Ventures Limited
Patents Assigned to Myrovlytis Technology Ventures Limited
COMPOUNDS FOR THE TREATMENT OF RENAL CELL CARCINOMA
Publication number:
20130150317
Abstract:
A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use in the treatment of renal cell carcinoma. In particular, the composition is suitable for use in the treatment of clear cell renal cell carcinoma. The composition is particularly useful for use in the treatment of renal cell carcinoma associated with Von Hippel-Lindau disease or Birt-Hogg-Dubé syndrome. A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use as a cytotoxic agent against FLCN-null or VHL-null renal cell carcinoma cells.
Type:
Application
Filed:
February 17, 2011
Publication date:
June 13, 2013
Applicant:
Myrovlytis Technology Ventures Limited
Inventors:
Eamonn Maher, Xiaohong Lu